PAUL COLEMAN: Open Payments
NPI 1104934645 · FORT BRAGG, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 23 payments from 11 companies in 2025. Trend: 2023 $160 · 2024 $328 · 2025 $412
Food & beverage: $412
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $78 |
| PFIZER INC. | 3 | $56 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Abbott Laboratories | 2 | $41 |
| Corcept Therapeutics | 2 | $40 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Novo Nordisk Inc | 2 | $30 |
| Merck Sharp & Dohme LLC | 2 | $29 |
| Exact Sciences Corporation | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
Products named: FREESTYLE LIBRE 3, Korlym, NURTEC ODT, LINZESS, QULIPTA, AIRSUPRA, Cologuard Collection Kit, VOQUEZNA.
Industry payments across NC — which companies pay providers there.
